US FDA Deems Sun Pharma’s Halol Plant Not Compliant with Manufacturing Rules
Sept 9 (Reuters) – Indian drugmaker Sun Pharmaceutical Industries said on Tuesday that the U.S. Food and Drug Administration (FDA) had determined its Halol plant, located in the western state of Gujarat, was not compliant with the regulator’s […]
Novartis to Acquire Tourmaline Bio for $1.4 Billion
BERLIN, Sept 9 – Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Focus […]